Hello and welcome to the details of Trump administration to end Medicare drug subsidies, putting millions of Americans over 65 at risk of higher costs and now with the details
Nevin Al Sukari - Sana'a - The change could leave some 25 million senior citizens facing serious cost increases for prescription drugs, the report said. ― Unsplash pic
NEW YORK, July 29 — US President Donald Trump’s administration plans to end federal subsidies for prescription drug plans offered to residents over 65 as part of its Medicare health insurance programme, The Wall Street Journal reported on Tuesday.
The change could leave some 25 million senior citizens facing serious cost increases for prescription drugs, the report said.
Citing anonymous Trump administration officials, the newspaper said US$3.6 billion (RM14.7 billion) in federal subsidies paid to stymie increases in Medicare insurance premiums will end this December.
Those on the subsidised plans will learn of their new premium rates in autumn.
The move could become a political issue ahead of November’s US midterm elections, with prescription drug costs a key concern for many retirees and people living on fixed incomes.
Health policy nonprofit KFF said the average premium for a subsidised plan was around US$36 a month.
A Trump administration official told the Journal that around a quarter of those on the subsidised plan will see their premiums decrease or stay the same in 2027, while another 30 per cent will have a monthly increase of under US$10.
The remaining 45 per cent will have a monthly cost increase between US$11 and US$20, the official said. — AFP
These were the details of the news Trump administration to end Medicare drug subsidies, putting millions of Americans over 65 at risk of higher costs for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.
